Here is the original post:
Subject: NYMXF
Date: Tue, Mar 17, 1998 04:49 EST
From: MizShort
Message-id: <19980317094901.EAA19559@ladder01.news.aol.com>
Nymox <NMX.M> shares jump on Alzheimer's claim
TORONTO, March 16 (Reuters) - The shares of Montreal-area biotechnology company Nymox Pharmaceutical Corp <NYMXF.O> jumped on Monday after it said it has found a major cause of Alzheimer's disease.
The shares of the Dorval, Quebec-based medical research company climbed 3.65 to 12.65 on volume of 168,750 shares in midday trading in Montreal, including a 52-week intraday high of 13.95.
On Nasdaq, it rose US$2-7/8 to US$9 on volume of 683,500 shares.
The rise came after the company told a Manhattan Alzheimer's Disease conference in New York that it believed it had found a major cause of Alzheimer's disease.
The company's research team said it had discovered a new human brain entity called the spheron which satisfies 20 criteria of validity as a causal entity for the disease.
Nymox had a number of treatments in development which it believed might eventually be capable of slowing or stopping the disease.
"We believe the proof on spherons is overwhelming, and our research on drugs that may slow or stop the disease is showing great potential," said Paul Averback, Nymox chief executive, in a release.
-----------------------------------
See previous post for the response to this release. By all rights, releases like this without any kind of response from NEOT could trigger a big price drop... especially if the company and its PR firm appear to be uninterested and unconcerned about the people who have invested in the company.
|
